PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $34,000 | +47.8% | 77,317 | +2.4% | 0.00% | – |
| Q4 2018 | $23,000 | -43.9% | 75,519 | +35.1% | 0.00% | – |
| Q3 2018 | $41,000 | +78.3% | 55,886 | +6.1% | 0.00% | – |
| Q2 2018 | $23,000 | +15.0% | 52,687 | +41.0% | 0.00% | – |
| Q1 2018 | $20,000 | -13.0% | 37,373 | +7.1% | 0.00% | – |
| Q4 2017 | $23,000 | -4.2% | 34,881 | -16.1% | 0.00% | – |
| Q3 2017 | $24,000 | -27.3% | 41,590 | +4.7% | 0.00% | – |
| Q2 2017 | $33,000 | -63.3% | 39,735 | -62.8% | 0.00% | -100.0% |
| Q1 2016 | $90,000 | -16.7% | 106,822 | +0.6% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +36.7% | 106,208 | +59.0% | 0.00% | 0.0% |
| Q3 2015 | $79,000 | -30.7% | 66,791 | +14.6% | 0.00% | 0.0% |
| Q2 2015 | $114,000 | +17.5% | 58,258 | +171.1% | 0.00% | – |
| Q3 2013 | $97,000 | +98.0% | 21,488 | +113.2% | 0.00% | – |
| Q2 2013 | $49,000 | – | 10,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|